In summary, there is no single cell-based in vitro assay that clearly detected two clonally independent diseases and all but one indicated BCR::ABL1 emerging in pre-existing JAK2 V617Fpos MPN. The gene discussed is ABL1; the disease is myeloproliferative neoplasm.